BEŠŠE, Andrej, Jiří ŠÁNA, Radek LAKOMÝ, Leoš KŘEN, Pavel FADRUS, Martin SMRČKA, Markéta HERMANOVÁ, Radim JANČÁLEK, Stefan REGULI, Radim LIPINA, Marek SVOBODA, Pavel ŠLAMPA and Ondřej SLABÝ. MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response. Tumor Biology. Dordrecht: Springer, 2016, vol. 37, No 6, p. 7719-7727. ISSN 1010-4283. Available from: https://dx.doi.org/10.1007/s13277-015-4654-x.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response
Authors BEŠŠE, Andrej (703 Slovakia, belonging to the institution), Jiří ŠÁNA (203 Czech Republic, belonging to the institution), Radek LAKOMÝ (203 Czech Republic, belonging to the institution), Leoš KŘEN (203 Czech Republic, belonging to the institution), Pavel FADRUS (203 Czech Republic, belonging to the institution), Martin SMRČKA (203 Czech Republic, belonging to the institution), Markéta HERMANOVÁ (203 Czech Republic, belonging to the institution), Radim JANČÁLEK (203 Czech Republic, belonging to the institution), Stefan REGULI (203 Czech Republic), Radim LIPINA (203 Czech Republic), Marek SVOBODA (203 Czech Republic, belonging to the institution), Pavel ŠLAMPA (203 Czech Republic) and Ondřej SLABÝ (203 Czech Republic, guarantor, belonging to the institution).
Edition Tumor Biology, Dordrecht, Springer, 2016, 1010-4283.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.650
RIV identification code RIV/00216224:14740/16:00088839
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1007/s13277-015-4654-x
UT WoS 000376464700071
Keywords (in Czech) Multiformní glioblastom; radiace; resistence; miRNA; miR-338-5p
Keywords in English Glioblastoma multiforme; GBM; Radiation resistance; miRNA; miRNA338-5p
Tags EL OK, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Eva Špillingová, učo 110713. Changed: 25/1/2017 16:33.
Abstract
Glioblastoma multiforme (GBM) is the most aggressive form of brain tumor. Despite radical surgery and radiotherapy supported by chemotherapy, the disease still remains incurable with an extremely low median survival rate of 12-15 months from the time of initial diagnosis. The main cause of treatment failure is considered to be the presence of cells that are resistant to the treatment. MicroRNAs (miRNAs) as regulators of gene expression are involved in the tumor pathogenesis, including GBM. MiR-338 is a brain-specific miRNA which has been described to target pathways involved in proliferation and differentiation. In our study, miR-338-3p and miR-338-5p were differentially expressed in GBM tissue in comparison to non-tumor brain tissue. Overexpression of miR-338-3p with miRNA mimic did not show any changes in proliferation rates in GBM cell lines (A172, T98G, U87MG). On the other hand, pre-miR-338-5p notably decreased proliferation and caused cell cycle arrest. Since radiation is currently the main treatment modality in GBM, we combined overexpression of pre-miR-338-5p with radiation, which led to significantly decreased cell proliferation, increased cell cycle arrest, and apoptosis in comparison to irradiation-only cells. To better elucidate the mechanism of action, we performed gene expression profiling analysis that revealed targets of miR-338-5p being Ndfip1, Rheb, and ppp2R5a. These genes have been described to be involved in DNA damage response, proliferation, and cell cycle regulation. To our knowledge, this is the first study to describe the role of miR-338-5p in GBM and its potential to improve the sensitivity of GBM to radiation.
Links
ED1.1.00/02.0068, research and development projectName: CEITEC - central european institute of technology
NT13514, research and development projectName: Analýza mikroRNA v glioblastomových kmenových buňkách: predikce léčebné odpovědi a identifikace nových terapeutických cílů u pacientů s glioblastomem
PrintDisplayed: 20/7/2024 23:24